Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle

British Journal of Pharmacology
E DelpónJ Tamargo

Abstract

1. The electrophysiological effects of E-3753, a new antiarrhythmic drug, were studied in guinea-pig papillary muscles. 2. E-3753 (10(-7) - 10(-4) M) produced a concentration-dependent decrease in the action potential amplitude and Vmax of the upstroke, shortened the action potential duration (APD) and shifted the resting membrane potential to less negative values. E-3753 also shortened the effective refractory period (ERP), lengthening the ERP relative to APD. 3. E-3753 (10(-5) M) shifted the membrane responsiveness curve along the voltage axis to more negative potentials. 4. In the presence of E-3753 (10(-5) M) trains of stimuli at rates between 0.5 and 3 Hz led to an exponential decline in Vmax (onset rate at 3 Hz, 0.05 +/- 0.009 per action potential), to a new steady-state level. This use-dependent Vmax block was augmented at higher rates of stimulation. The time constant for the recovery of Vmax from the use-dependent block was 41.1 +/- 4.8 s. 5. E-3753 (10(-5) - 10(-4) M) had no effect on the characteristics of the slow action potentials elicited by isoprenaline in ventricular fibres depolarized by 27 mM KCl. 6. The slow onset of use-dependent block during repetitive activity and the slow offset kinetics of use-dependent ...Continue Reading

References

Nov 14, 1977·Biochimica Et Biophysica Acta·L M Hondeghem, B G Katzung
Nov 1, 1987·Journal of Cardiovascular Pharmacology·C ValenzuelaJ Tamargo
Oct 1, 1988·Journal of Cardiovascular Pharmacology·C ValenzuelaJ Tamargo
Jun 19, 1985·European Journal of Pharmacology·A VarroB Surawicz
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·L M Hondeghem, B G Katzung
Nov 1, 1980·Journal of Molecular and Cellular Cardiology·K R Courtney
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss

❮ Previous
Next ❯

Citations

Jun 18, 1991·European Journal of Pharmacology·F Pérez-VizcainoJ Tamargo
Oct 1, 1992·British Journal of Pharmacology·E DelpónJ Tamargo
Jan 13, 2006·British Journal of Pharmacology·M J A Walker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.